Nanox to Release Quarterly Earnings Following VasoHealthcare IT Acquisition
Nanox Imaging Ltd (NASDAQ:NNOX) is set to release its quarterly earnings report on Thursday, November 20, 2025. Wall Street consensus anticipates an earnings per share (EPS) of -$0.175 and revenue of approximately $3.5 million for the quarter.
This financial disclosure follows the company's recent announcement of an agreement to acquire VasoHealthcare IT Inc. from Vaso Corporation. The acquisition is intended to accelerate the U.S. rollout of Nanox's artificial intelligence solutions. The transaction is expected to close in a few weeks, pending customary conditions.
Regarding its financial position, NNOX maintains a strong liquidity level with a current ratio of 4.19. The company also reports a low debt-to-equity ratio of 0.05, suggesting a limited reliance on debt financing.
Despite these strengths, the company faces profitability challenges, with a negative price-to-earnings (P/E) ratio of -3.49 and an enterprise value to operating cash flow ratio of -3.98. However, a high price-to-sales ratio of 16.35 indicates significant investor expectations for future revenue growth.
For further information, see the company's financial health and investor profile.
Nano-X Imaging Ltd. (NNOX) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.